AI 聊天
Loading data for NPCE — first visit, this takes a few seconds.

NeuroPace, Inc.

NPCE · NasdaqGM · USD

14.25 -0.34 (-2.33%)

收盘价: Sep 15, 2026, 8:00 PM

市值
$489.1M
成交量
96.8K
下次财报日期
Nov 3, 2026

NeuroPace, Inc.(NPCE)股价、分析与数据

内在价值

正在加载内在价值…

分析师预测

股票预测 →

分析师预测不可用

12个月目标价 · n/a 位分析师

分析师一致意见: n/a

时间间隔:1D
正在加载K线和信号…

财务表现

查看财务 →

加载中...

最新财报

已公布较预期同比变动
营收$22.83Mn/a+17.05%
每股收益(TTM)-$0.18+$0.01+14.29%

下次财报

盘中。

预估 · 升级 →

查看财报详情 →

指标

买价
10.16
市值
489M
净利润(TTM)
-16.2M
1.95
-0.46
n/a
-64.87
市净率(TTM)
41.07
市销率(TTM)
4.57
财报日期
Nov 3, 2026
卖价
17.12
成交量
96,842
20日均量
188,311
开盘价
14.48
前收盘价
14.59
日内区间
14.05 - 14.49
52周区间
9.22 - 19.60
分红
n/a
除息日
n/a

关于 NeuroPace, Inc.

查看公司资料 →
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California. Medical Devices · Healthcare

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

板块 Healthcare
上市日期 Apr 22, 2021
员工人数 220
交易所 NasdaqGM
股票代码 NPCE